High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary: We examined nevi and melanomas in 10 xeroderma pigmentosum (XP) patients with defective DNA repair. The lesions had a lentiginous appearance with markedly increased numbers of melanocytes. Using laser capture microdissection, we performed DNA sequencing of 18 benign and atypical nevi and 75 melanomas (melanoma in situ and invasive melanomas). The nevi had a similar high frequency of PTEN mutations as melanomas [61% (11/18) versus 53% (39/73)]. Both had a very high proportion of UV‐type mutations (occurring at adjacent pyrimidines) [91% (10/11) versus 92% (36/39)]. In contrast to melanomas in the general population, the frequency of BRAF mutations (11%, 7/61), NRAS mutations (21%, 13/62), and KIT mutations (21%, 6/28) in XP melanomas was lower than for PTEN. Phospho‐S6 immunostaining indicated activation of the m TOR pathway in the atypical nevi and melanomas. Thus, the clinical and histological appearances and the molecular pathology of these UV‐related XP nevi and melanomas were different from nevi and melanomas in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756 · cited 1×
“In the invasive melanomas in the XP patients and in the general population, the proportion of PTEN C to T mutations was greater than T to C mutations (69% and 58%, respectively) which were similar to the previous reports (Berger et al., 2012; Wei et al., 2011).”
ResultShining a light on xeroderma pigmentosum
DiGiovanna, J. J., & Kraemer, K. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.426 · Cited by 547 · cited 3×
“Xeroderma pigmentosum (XP) is an autosomal recessive cancer-prone disease with photosensitivity and defective DNA repair of UV-induced DNA damage such as cyclobutane pyrimidine dimers and 6-4 pyrimidine-pyrimidone photoproducts (DiGiovanna and Kraemer, 2012).”
BackgroundSelf-citationBradford, P. T., Goldstein, A. M., Tamura, D., Khan, S. G., Ueda, T., Boyle, J., Oh, K.-S., Imoto, K., Inui, H., Moriwaki, S.-I., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.083022 · Cited by 480 · cited 4×
“27; 454–464 ORIGINAL ARTICLE cancers under the age of 20 yr (Bradford et al., 2011).”
BackgroundSelf-citationmTOR Is Activated in the Majority of Malignant Melanomas
Karbowniczek, M., Spittle, C. S., Morrison, T., Wu, H., & Henske, E. P. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701074 · Cited by 168
Daya-Grosjean, L., & Sarasin, A. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.11.013 · Cited by 142 · cited 1×
“These skin cancers in XP patients have been reported to show molecular evidence of UV damage (D’Errico et al., 2000; Daya-Grosjean and Sarasin, 2005;Wang et al., 2009).”
BackgroundWang, Y., Woodgate, R., McManus, T. P., Mead, S., McCormick, J. J., & Maher, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3073 · Cited by 120 · cited 2×
“These mutations in the XP patients might be related to bypass polymerase iota which tends to induce T to C transitions (Dumstorf et al., 2006; Wang et al., 2007).”
BackgroundResultSelf-citationKraemer, K. H. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690080084012 · Cited by 1
Self-citation
Cited by
Brash, D. E. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12377 · Cited by 401
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
Black, J. O. (2016) · Head and Neck Pathology · doi:10.1007/s12105-016-0707-8 · Cited by 166
“DNA sequencing studies have shown that PTEN mutations are far more frequent (53 %) in XP melanomas than in the general population (16 %), and the PTEN mutations are characteristic of UV radiation-induced changes [21].”
BackgroundResultInfluentialEvangelisti, C., Cenni, V., & Lattanzi, G. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12928 · Cited by 53
Metadata
- Authors
- Masaki, T., Wang, Y., DiGiovanna, J. J., Khan, S. G., Raffeld, M., Beltaifa, S., Hornyak, T. J., Darling, T. N., Lee, C. R., & Kraemer, K. H.
- Venue
- Pigment Cell & Melanoma Research
- Publisher
- Wiley
- Published
- 2014-02-21
- Volume
- 27
- Issue
- 3
- Pages
- 454-464
- ISSN
- 1755-1471 (ISSN-L)
- 1755-148X
- OpenAlex
- W2138959658
- Cited by
- 41
- References
- 9
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. https://app.cochat.ai/papers/10.1111/pcmr.12226
- The paper
- Masaki, T., Wang, Y., DiGiovanna, J. J., Khan, S. G., Raffeld, M., Beltaifa, S., Hornyak, T. J., Darling, T. N., Lee, C. R., & Kraemer, K. H. (2014). High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.12226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.